{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:05:30Z","timestamp":1776423930065,"version":"3.51.2"},"reference-count":39,"publisher":"BMJ","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart"],"accepted":{"date-parts":[[2011,4,9]]},"published-print":{"date-parts":[[2011,7,1]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Prosthesis\u2013patient mismatch (PPM) is characterised by the effects of inadequate prosthesis size relative to body surface area (BSA). It is uncertain whether PPM after mitral valve replacement impacts upon clinical outcome. This was examined in an Australian population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>From 2001 to 2009, 1006 mechanical and bioprosthetic mitral valves were implanted across 10 institutions. Effective orifice areas (EOA) were obtained from a literature review of in vivo echocardiographic data. Absent, moderate and severe PPM was defined as an indexed EOA (EOA\/BSA) of &gt;1.20\u2005cm<jats:sup>2<\/jats:sup>\/m<jats:sup>2<\/jats:sup>, &gt;0.90 to \u22641.20\u2005cm<jats:sup>2<\/jats:sup>\/m<jats:sup>2<\/jats:sup> and \u22640.9\u2005cm<jats:sup>2<\/jats:sup>\/m<jats:sup>2<\/jats:sup>, respectively. Early outcomes and 7-year survival were compared between these three groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>PPM was absent in 34%, moderate in 53% and severe in 13% of patients. Patients with PPM were more likely to be male (42% vs 52% vs 62%, p&lt;0.0001) and obese (14% vs 20% vs 56%, p&lt;0.0001). Postoperatively there was similar 30-day mortality (5% vs 5% vs 6%, p=0.83) and early any mortality\/morbidity (24% vs 27% vs 29%, p=0.40). Seven-year survival was similar between groups (72\u00b14.1% vs 76\u00b13.2% vs 69\u00b110.3%, p=0.76). PPM did not predict adverse events after logistic and Cox regressions with and without propensity score adjustment. Subgroup analyses of those with isolated mitral valve surgery, patients with preoperative congestive heart failure and non-obese patients failed to show an association between PPM and mid-term mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Overall, PPM was not associated with poorer early outcomes or mid-term survival. Oversizing valves may be technically hazardous and do not yield superior outcomes. Easier implantation by appropriate sizing appears justified.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/hrt.2010.219576","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T23:42:04Z","timestamp":1305934924000},"page":"1074-1081","source":"Crossref","is-referenced-by-count":26,"title":["Impact of prosthesis\u2013patient mismatch after mitral valve replacement: a multicentre analysis of early outcomes and mid-term survival"],"prefix":"10.1136","volume":"97","author":[{"given":"William Y","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Hon","family":"Yap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip A","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diem T","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilbert C","family":"Shardey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian A","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2011,5,20]]},"reference":[{"key":"2025092006082637000_97.13.1074.1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.45.3.331"},{"key":"2025092006082637000_97.13.1074.2","doi-asserted-by":"publisher","DOI":"10.1016\/1010-7940(92)90019-T"},{"key":"2025092006082637000_97.13.1074.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2006.04.007"},{"key":"2025092006082637000_97.13.1074.4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.587022"},{"key":"2025092006082637000_97.13.1074.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(03)00591-9"},{"key":"2025092006082637000_97.13.1074.6","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000085167.67105.32"},{"key":"2025092006082637000_97.13.1074.7","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2008.151928"},{"key":"2025092006082637000_97.13.1074.8","first-page":"III5","article-title":"Prosthesis-patient mismatch affects survival after aortic valve replacement","volume":"2","author":"Rao","year":"2000","journal-title":"Circulation"},{"key":"2025092006082637000_97.13.1074.9","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2009.177220"},{"key":"2025092006082637000_97.13.1074.10","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2010.200428"},{"key":"2025092006082637000_97.13.1074.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(02)03680-9"},{"key":"2025092006082637000_97.13.1074.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2010.05.018"},{"key":"2025092006082637000_97.13.1074.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00017-X"},{"key":"2025092006082637000_97.13.1074.14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.631549"},{"key":"2025092006082637000_97.13.1074.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.10.073"},{"key":"2025092006082637000_97.13.1074.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2006.12.071"},{"key":"2025092006082637000_97.13.1074.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2007.04.031"},{"key":"2025092006082637000_97.13.1074.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2009.01.056"},{"key":"2025092006082637000_97.13.1074.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2010.10.002"},{"key":"2025092006082637000_97.13.1074.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2010.11.001"},{"key":"2025092006082637000_97.13.1074.21","unstructured":"ATS Medical Inc. Pre-Market Approval Application\u2014Summary of Safety and Effectiveness. Washington, DC: U.S. Food and Drug Administration, 2000. http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf\/P990046b.pdf (accessed 15 Jul 2010)."},{"key":"2025092006082637000_97.13.1074.22","unstructured":"Medical Carbon Research Institute LLC. Pre-Market Approval Application\u2014Summary of Safety and Effectiveness Data On-X\u00ae Prosthetic Heart Valve, Models ONXM and ONXMC. Washington, DC: U.S. Food and Drug Administration, 2002. http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf\/P000037S001b.pdf (accessed 15 Jul 2010)."},{"key":"2025092006082637000_97.13.1074.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)80083-6"},{"key":"2025092006082637000_97.13.1074.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2004.11.011"},{"key":"2025092006082637000_97.13.1074.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2007.02.027"},{"key":"2025092006082637000_97.13.1074.26","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0735-1097(93)90681-P","article-title":"Echocardiographic description of the CarboMedics bileaflet prosthetic heart valve","volume":"21","author":"Chambers","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"2025092006082637000_97.13.1074.27","unstructured":"St Jude Medical Inc. Pre-Market Approval Application\u2014Summary of Safety and Effectiveness SJM Biocor\u00ae Valve and SJM Biocor\u00ae Supra Valve. Washington, DC: U.S. Food and Drug Administration, 2005. http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf4\/P040021b.pdf (accessed 15 Jul 2010)."},{"key":"2025092006082637000_97.13.1074.28","unstructured":"St Jude Medical Inc. Instructions for Use\u2014Stented Porcine Tissue Valves EpicTM\/EpicTM Supra. St Paul, Minnesota: St Jude Medical Inc, 2007. http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf4\/P040021S004b.pdf (accessed 15 Jul 2010)."},{"key":"2025092006082637000_97.13.1074.29","doi-asserted-by":"publisher","DOI":"10.1067\/mtc.2002.122552"},{"key":"2025092006082637000_97.13.1074.30","unstructured":"Medtronic Heart Valves. Pre-Market Approval Application\u2014Summary of Safety and Effectiveness Mosaic\u00ae Porcine Bioprosthesis. Washington, DC: U.S. Food and Drug Administration, 2000. http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf\/P990064b.pdf (accessed 15 Jul 2010)."},{"key":"2025092006082637000_97.13.1074.31","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(01)02539-5"},{"key":"2025092006082637000_97.13.1074.32","doi-asserted-by":"crossref","unstructured":"Firstenberg MS Morehead AJ Thomas JD . Short-term hemodynamic performance of the mitral Carpentier-Edwards PERIMOUNT pericardial valve. Carpentier-Edwards PERIMOUNT Investigators. Ann Thorac Surg 2001;71.","DOI":"10.1016\/S0003-4975(01)02514-0"},{"key":"2025092006082637000_97.13.1074.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2004.05.006"},{"key":"2025092006082637000_97.13.1074.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2010.03.031"},{"key":"2025092006082637000_97.13.1074.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.09.022"},{"key":"2025092006082637000_97.13.1074.36","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.6.820"},{"key":"2025092006082637000_97.13.1074.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2009.07.039"},{"key":"2025092006082637000_97.13.1074.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2004.10.021"},{"key":"2025092006082637000_97.13.1074.39","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.686717"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/hrt.2010.219576","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T13:08:35Z","timestamp":1758373715000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/hrt.2010.219576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,20]]},"references-count":39,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2011,6,4]]},"published-print":{"date-parts":[[2011,7,1]]}},"alternative-id":["10.1136\/hrt.2010.219576"],"URL":"https:\/\/doi.org\/10.1136\/hrt.2010.219576","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,20]]}}}